NCT03214159View on ClinicalTrials.gov

Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

August 31, 2017

Study Completion Date

September 20, 2017

Conditions
Healthy Volunteer
Interventions
DRUG

Ritonavir Tablet 100mg

Ritonavir Tablet 100mg is a generic product manufactured by Ascletis Pharmaceutical Co., Ltd.

DRUG

NORVIR tablet 100mg

NORVIR Tablet is a generic product manufactured by AbbVie. NORVIR Tablet 100mg will be used as a comparator drug for the BE study.

Trial Locations (2)

310003

First affiliated hospital of Zhejiang University, Hangzhou

First affiliated hospital of Zhejiang University, Hanzhou

Sponsors
All Listed Sponsors
collaborator

Ascletis Pharmaceutical Co., Ltd.

UNKNOWN

lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT03214159 - Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter